Skip to main content

Table 1

From: O213. Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial

HIV RNA

DRV/r mono (n=105)

DRV/r + 2NRTIs (n=114

HIV RNA <50, OD = background

79.0%

80.7%

HIV RNA <50, detectable

17.1%

14.9%

HIV RNA 50-400 copies/mL

2.9%

3.5%

HIV RNA <400 copies/mL

1.0%

0.9%